Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: India Globalization Capital, Inc. IGC

MissionIRNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Launches Pharmaceutical Cannabinoid Pipeline Websites

Posted on December 7, 2017 by MissionIR

India Globalization Capital (NYSE American: IGC) this morning announced the launching of two new websites (www.IGCPharma.com and www.Hyalolex.com) to detail its initiatives, development timeline and pipeline of pharmaceutical cannabinoids for use in treatment of the symptoms of Alzheimer’s disease, pain, … Continue reading →

Posted in India Globalization Capital, Inc. IGC, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – India Globalization Capital, Inc.’s (NYSE: IGC) Future Business Strategy

Posted on November 30, 2017 by MissionIR

India Globalization Capital (NYSE American: IGC) is strategizing the marketing of its products and select target markets for continued growth. A recent article highlights next year’s and future year’s prospects and IGC plans, stating, “[IGC] sees opportunities in 2018, primarily … Continue reading →

Posted in India Globalization Capital, Inc. IGC, MissionIRNewsBreaks | Leave a comment

India Globalization Capital, Inc. (NYSE: IGC) Enters MOU for Distribution in Germany, Plans to Commercialize Liquid Formulation of Hyalolex

Posted on November 29, 2017 by MissionIR

IGC is scheduled to market a liquid formulation of its drug, IGC-AD1 (Hyalolex), in 2018; company is eyeing markets in Germany, Canada and U.S. states where licensed medical cannabis has been legalized IGC is exclusive licensee of a U.S. patent … Continue reading →

Posted in India Globalization Capital, Inc. IGC | Leave a comment

MissionIRNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Reports Q2 2018 Financial Results

Posted on November 20, 2017 by MissionIR

India Globalization Capital (NYSE American: IGC) today reported financial results for the second quarter ended September 30, 2017, as well as an overview of recent operational highlights. The company’s legacy division which consists of rental of heavy equipment, commodities trading, … Continue reading →

Posted in India Globalization Capital, Inc. IGC, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Releases Results of Annual Shareholders Meeting

Posted on November 14, 2017 by MissionIR

India Globalization Capital, Inc. (NYSE American: IGC) yesterday announced that during its 2016-2017 Annual Meeting of Shareholders on November 8, 2017, voting on Proposals Three and Four was adjourned to November 22, 2017 at 11:00 a.m. EST due to the … Continue reading →

Posted in India Globalization Capital, Inc. IGC, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Regains Listing Compliance

Posted on November 10, 2017 by MissionIR

India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced that it has regained NYSE American listing compliance. The company received a letter on November 9, 2017, from … Continue reading →

Posted in India Globalization Capital, Inc. IGC, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – India Globalization Capital (NYSE: IGC) Avoids Regulatory Costs through Cannabis-based Drug Candidates

Posted on November 6, 2017 by MissionIR

India Globalization Capital (NYSE AMERICAN: IGC) is developing a portfolio of products using cannabis-based “combination therapies” for the treatment of various life-altering conditions. The company is employing a distinctive strategy to bring these drug candidates to market. An article discussing … Continue reading →

Posted in India Globalization Capital, Inc. IGC, MissionIRNewsBreaks | Leave a comment

India Globalization Capital, Inc. (NYSE: IGC) Targets Multiple Health Concerns with Cannabis-based Therapies

Posted on November 2, 2017 by MissionIR

6 patents filed for pain management, eating disorders and epilepsy Additional patents underway for PTSD, depression, Alzheimer’s and Parkinson’s disease Revenue potential of each cannabis-based therapy could fetch between $100 million to $500 million India Globalization Capital (NYSE AMERICAN: IGC) … Continue reading →

Posted in India Globalization Capital, Inc. IGC | Leave a comment

MissionIRNewsBreaks – India Globalization Capital (NYSE: IGC) Aims to Fast-Track Release of Hyalolex in Recreational Cannabis States

Posted on November 2, 2017 by MissionIR

As a first mover in the cannabis-based combination therapy space, India Globalization Capital (NYSE AMERICAN: IGC) is preparing for the launch of its breakthrough treatment aimed at reducing beta-amyloid building up in Alzheimer’s patients, Hyalolex. The classification as a combination … Continue reading →

Posted in India Globalization Capital, Inc. IGC, MissionIRNewsBreaks | Leave a comment

India Globalization Capital, Inc. (NYSE: IGC) Could Release Potential Blockbuster Alzheimer’s Treatment in Early 2018

Posted on October 25, 2017 by MissionIR

On the verge of releasing potential Cannabis-based blockbuster Alzheimer’s treatment Company is able to hugely accelerate release of this treatment in recreational cannabis states Market potential for drugs to treat and prevent Alzheimer’s is in the billions of dollars According … Continue reading →

Posted in India Globalization Capital, Inc. IGC | Leave a comment